• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌:信号通路中的突变

Colorectal cancer: mutations in a signalling pathway.

作者信息

Parsons D Williams, Wang Tian-Li, Samuels Yardena, Bardelli Alberto, Cummins Jordan M, DeLong Laura, Silliman Natalie, Ptak Janine, Szabo Steve, Willson James K V, Markowitz Sanford, Kinzler Kenneth W, Vogelstein Bert, Lengauer Christoph, Velculescu Victor E

机构信息

The Sidney Kimmel Comprehensive Cancer Center and The Howard Hughes Medical Institute, The Johns Hopkins University Medical Institutions, Baltimore, Maryland 21231, USA.

出版信息

Nature. 2005 Aug 11;436(7052):792. doi: 10.1038/436792a.

DOI:10.1038/436792a
PMID:16094359
Abstract

Protein kinases are enzymes that are important for controlling cellular growth and invasion, and their malfunction is implicated in the development of some tumours. We analysed human colorectal cancers for genetic mutations in 340 serine/threonine kinases and found mutations in eight genes, including in three members of the phosphatidylinositol-3-OH kinase (PI(3)K) pathway. The discovery of this mutational activation of a key cell-signalling pathway may provide new targets for therapeutic intervention.

摘要

蛋白激酶是对控制细胞生长和侵袭很重要的酶,其功能异常与某些肿瘤的发生有关。我们分析了340种丝氨酸/苏氨酸激酶的基因突变情况,在人类结直肠癌中发现了8个基因的突变,其中包括磷脂酰肌醇-3-羟基激酶(PI(3)K)途径的三个成员。这一关键细胞信号通路的突变激活的发现可能为治疗干预提供新的靶点。

相似文献

1
Colorectal cancer: mutations in a signalling pathway.结直肠癌:信号通路中的突变
Nature. 2005 Aug 11;436(7052):792. doi: 10.1038/436792a.
2
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.人乳腺癌细胞系中的磷脂酰肌醇-3-羟基激酶或RAS途径突变。
Mol Cancer Res. 2007 Feb;5(2):195-201. doi: 10.1158/1541-7786.MCR-06-0263.
3
PIK3CA gene mutations in breast carcinoma in Malaysian patients.马来西亚患者乳腺癌中的PIK3CA基因突变
Cancer Genet Cytogenet. 2008 Dec;187(2):74-9. doi: 10.1016/j.cancergencyto.2008.07.005.
4
Mutational analysis of PDPK1 kinase domain in gastric, colorectal and lung carcinomas.胃癌、结直肠癌和肺癌中PDPK1激酶结构域的突变分析。
Acta Oncol. 2006;45(3):340-1. doi: 10.1080/02841860500468968.
5
Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.具有截短型转化生长因子β受体II(TGFbetaRII)突变的微卫星不稳定结直肠癌细胞系对内源性转化生长因子β(TGFbeta)仍敏感。
J Pathol. 2007 Nov;213(3):257-65. doi: 10.1002/path.2235.
6
Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA.具有突变型或野生型PIK3CA的一组人结肠癌细胞系中磷脂酰肌醇-3-激酶信号传导的比较。
FEBS Lett. 2005 Sep 26;579(23):5123-8. doi: 10.1016/j.febslet.2005.07.096.
7
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma.缺乏磷脂酰肌醇-3激酶γ催化亚基的小鼠中的结直肠癌
Nature. 2000 Aug 24;406(6798):897-902. doi: 10.1038/35022585.
8
Cancer genetics of sporadic colorectal cancer: BRAF and PI3KCA mutations, their impact on signaling and novel targeted therapies.散发性结直肠癌的癌症遗传学:BRAF和PI3KCA突变、它们对信号传导的影响及新型靶向治疗
Anticancer Res. 2006 Mar-Apr;26(2A):1077-84.
9
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.丝裂原活化蛋白激酶信号传导在前列腺肿瘤中被激活,但不是由B-RAF突变介导的。
Eur Urol. 2006 Nov;50(5):1102-9; discussion 1109-10. doi: 10.1016/j.eururo.2005.11.031. Epub 2006 Jan 6.
10
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.中东人群中携带PIK3CA突变的结直肠癌的临床病理分析
Oncogene. 2008 Jun 5;27(25):3539-45. doi: 10.1038/sj.onc.1211013. Epub 2008 Jan 14.

引用本文的文献

1
Rapamycin rescues APC-mutated colon organoid differentiation.雷帕霉素可挽救APC突变的结肠类器官分化。
Cancer Gene Ther. 2025 Jul 23. doi: 10.1038/s41417-025-00935-3.
2
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease.微小RNA对细胞凋亡途径的调控:一种治疗阿尔茨海默病的策略。
Mol Neurobiol. 2025 Apr 12. doi: 10.1007/s12035-025-04833-5.
3
Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems.结直肠癌的纳米医学创新:靶向药物和基因递送系统的进展
Med Oncol. 2025 Mar 17;42(4):113. doi: 10.1007/s12032-025-02670-z.
4
Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting.靶向肺癌中的PI3K/AKT/mTOR信号通路:作用机制与治疗靶点
Front Pharmacol. 2025 Feb 18;16:1516583. doi: 10.3389/fphar.2025.1516583. eCollection 2025.
5
Targeting carbohydrate metabolism in colorectal cancer - synergy between DNA-damaging agents, cannabinoids, and intermittent serum starvation.靶向结直肠癌中的碳水化合物代谢——DNA损伤剂、大麻素与间歇性血清饥饿之间的协同作用
Oncoscience. 2024 Nov 12;11:99-105. doi: 10.18632/oncoscience.611. eCollection 2024.
6
Paternal age, de novo mutations, and offspring health? New directions for an ageing problem.父亲年龄、新生突变与后代健康?老龄化问题的新方向。
Hum Reprod. 2024 Dec 1;39(12):2645-2654. doi: 10.1093/humrep/deae230.
7
Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.结直肠癌中的细胞和分子事件:生物学机制、细胞死亡途径、耐药性及信号网络相互作用
Discov Oncol. 2024 Jul 20;15(1):294. doi: 10.1007/s12672-024-01163-1.
8
Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.女性腋窝淋巴结转移性腺癌或未分化癌不明原发灶的临床病理特征和基因组分析。
J Cancer Res Clin Oncol. 2024 May 15;150(5):256. doi: 10.1007/s00432-024-05783-6.
9
National Trends in the Incidence of Sporadic Malignant Colorectal Polyps in Young Patients (20-49 Years): An 18-Year SEER Database Analysis.年轻患者(20 - 49岁)散发性恶性大肠息肉发病率的全国趋势:一项为期18年的监测、流行病学和最终结果(SEER)数据库分析
Medicina (Kaunas). 2024 Apr 21;60(4):673. doi: 10.3390/medicina60040673.
10
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment.PI3K/Akt/mTOR 信号通路作为结直肠癌治疗的靶点。
Int J Mol Sci. 2024 Mar 9;25(6):3178. doi: 10.3390/ijms25063178.